Menu

Leukemia/Lymphoma/Hematologic Malignancies

Heme Team

The multidisciplinary team of experts within the Hematologic Malignancies Program is among the nation’s most experienced who have expertise in routine, rare and complex hematologic malignancies; treating advanced blood cancers with clinical trials, immunotherapy and other cellular therapies. Rutgers Cancer Institute is one of the first programs in the state to offer CAR T-cell therapy. CAR-T cell therpay is currently only offered at centers such as ours that perform stem cell transplants, have specially trained clinicians and healthcare personnel, and are FACT (Foundation for the Accreditation of Cellular Therapy) certified.

The Program’s approach to cancer care offers the full spectrum of therapeutic procedures and advanced treatment options for patients with acute and chronic leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, myelodysplasia, myeloproliferative diseases, and other hematologic malignancies.  Rutgers Cancer Institute in collaboration with Robert Wood Johnson University Hospital is home to one of only two blood and marrow transplant programs in the state and the only one at an NCI-designated Comprehensive Cancer Center.  

To help patients better understand and navigate their disease, our program offers a full line of oncology support services including social workers, dieticians, support groups, on-site pharmacy, and financial counselors The Program integrates a spectrum of clinical, basic, and translational research activities, assuring close collaboration between basic scientists and clinicians for the rapid translation of research discoveries to clinical care and to enlist the assistance of basic researchers in solving clinical problems.

Rutgers Cancer Institute is recognized as a Center of Excellence by the Myelodysplastic Syndromes (MDS) Foundation in the research, diagnosis and treatment of MDS disorders.

 

Clinical Trials:

Useful Links From The Resource and Learning Center:

 

Roger Strair, MD, PhD, Chief, Blood Disorders
Dennis Cooper, MD, Chief, Blood and Marrow Transplantation
Rajat Bannerji, MD, PhD, Chief, Hematologic Malignancies
Andrew M. Evens, DO, MSc, FACP, Associate Director for Clinical Services and Director, Lymphoma Program


Hematologist/Oncologists

Roger Strair, MD, PhD, Chief, Blood Disorders
Dennis Cooper, MD, Chief, Blood and Marrow Transplantation
Rajat Bannerji, MD, PhD, Chief, Hematologic Malignancies
Andrew M. Evens, DO, MSc, FACP, Associate Director for Clinical Services and Director, Lymphoma Program


Radiation Oncologist

Rahul R, Parikh, MD, Medical Director, Laurie Proton Therapy Center


Nurses

Laura Ciavolino, APN, Advanced Practice Nurse
Kara Saggiomo, ANP-BC, AOCNP, Advanced Practice Nurse
Alissa Gabel, APN, Advanced Practice Nurse
Josephine Machado, APN, Advanced Practice Nurse
Kathryn Singer, ANP-BC, AOCNP, Advanced Practice Nurse
Joyce Herrera, RN, BSN, OCN, Nurse Clinician
Jacqueline Manago, BSN, RN, BMTCN, Nurse Clinician and Bone Marrow Transplant Coordinator
Mary Kate McGrath, ANP-BC, BMTCN, OCN, Bone Marrow Transplant Coordinator
Anne Tyno, NP, Nurse Practitioner and Bone Marrow Transplant Coordinator
Madelline Cruz, BSN, RN, Inpatient Oncology Nurse Navigator
Jennifer Edmonds, RN, Oncology Nurse Navigator


Support Services

Lauren Kriegel, MSW, LSW, Social Worker
Deborah Leif, MSW, LCSW, Social Worker
Rosemarie Slirzewski, MSW, LCSW, Social Worker


Research Scientist

Rohini Navalekar BE, MPA, CCRP

image that says give now and support cancer research with link to giving page

 

 

 

 

Logo for ScreenNJ program and link to website

 

 

 

 

Robert Wood Johnson Barnabas Health logo with link to Partners page

 

  

 

 

 

Big Ten Cancer Research Consortium

 

 

 

 

Rutgers Health